https://doi.org/10.1200/jco.21.02698
P
Peter Martin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
439
Papers
11.7K
Citations
50
h-index
149
i10-index
Peter Martin is an academic researcher from UPMC Health System. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Viral-associated cancers and disorders. The author has an h-index of 50, co-authored 374 publications.
ORCID: 0000-0001-7813-1551Papers by this author
worksTreatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts
2022 · Journal of Clinical Oncology · 68 citations
Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells
2016 · Blood Cancer Journal · 60 citations
https://doi.org/10.1038/bcj.2016.93
Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma
2018 · British Journal of Haematology · 50 citations
https://doi.org/10.1111/bjh.15720
Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients
2016 · Clinical Epigenetics · 49 citations
https://doi.org/10.1186/s13148-016-0245-y
Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma
2014 · Blood Cancer Journal · 47 citations
https://doi.org/10.1038/bcj.2014.71
Improving implementation of psychological interventions to older adult patients with cancer: Convening older adults, caregivers, providers, researchers
2018 · Journal of Geriatric Oncology · 20 citations
https://doi.org/10.1016/j.jgo.2018.04.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat